BeyondSpring

BYSINasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$26.551 M

$0.65 -4.90%

Close of 6 Nov 2026

As of 6 Nov 2026, BeyondSpring (BYSI) has a market capitalization of $26.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$1.01M

Loss-making

Shares outstanding

41,119,820

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#367Annovis BioANVS$28.1M
#368Adicet BioACET$27.6M
#369BeyondSpringBYSI$26.6M
#370Abvc BiopharmaABVC$26.3M
#371Transcode TherapeuticsRNAZ$25.4M

What if BeyondSpring were worth as much as…

Open the what-if tool →

Gold $28.2T

$686,697.40

Per share 1,063,493× higher

Bitcoin $1.53T

$37,156.00

Per share 57,544× higher

Apple $5.02T

$121,979.68

Per share 188,911× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for BeyondSpring are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.